Aseptuva AG
PrivateLast Round
Grant
May 30, 2025
Total Funding Raised
$2.29M
Company Overview
Aseptuva AG is a medical technology company that develops automated Far-UVC disinfection adaptors for catheters to prevent hospital-acquired infections.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aseptuva AG Comparables
Compare Aseptuva AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Finsen Technologies | 82% | |
| 3C GROUPS A/S | 80% | |
| Xenex Disinfection Services Inc. | 76% |
Aseptuva AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 30, 2025 | ||||
| Seed | Nov 3, 2023 | ||||
| Grant | Nov 3, 2023 | ||||
| Pre Seed | Aug 30, 2022 | ||||
| Grant | Jul 1, 2020 |
Aseptuva AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fortyone AG | Pre Seed, Seed |
| ValueMaker AG | Pre Seed, Seed |
| Innosuisse | Grant |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2022
$520K round with Fortyone AG and ValueMaker AG.
Recent news
Latest coverage and updates
- receives_financingSep 19, 2026
Aseptuva Ltd receives financing of $4.58M in Series A.
- receives_financingSep 19, 2026
Aseptuva Ltd receives financing of $2.2M in Seed.
- hiresSep 18, 2026
Aseptuva Ltd hired Daniel Delfosse as Board of Directors on Jan 1st '26.
- receives_financingSep 18, 2026
Aseptuva Ltd received financing of $2.91M in Seed on Jul 1st '25.
- is_developingSep 18, 2026
Aseptuva Ltd is developing Far-UVC disinfection technology on Sep 18th '26.
Aseptuva AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aseptuva AG's valuation, stock price, and market status.
Is Aseptuva AG a public or private company?
Aseptuva AG is a private company.
What is the current stock price of Aseptuva AG?
Aseptuva AG is a private company with no public stock price. No recent secondary market data is available.
How much is Aseptuva AG worth (valuation)?
Valuation information for Aseptuva AG is not publicly available.
Can I buy Aseptuva AG stock?
Aseptuva AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aseptuva AG's last funding round?
Aseptuva AG's most recent funding round was Grant on May 30, 2025.
Who are the main investors in Aseptuva AG?
Key investors in Aseptuva AG include Fortyone AG, ValueMaker AG, Innosuisse, Venture Kick.
Will Aseptuva AG IPO soon?
No public IPO plans have been announced for Aseptuva AG.
How can I track Aseptuva AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aseptuva AG's secondary market activity and sign up for updates.